Patients atteints d’un cancer gastrique localisé MSI/dMMR, pas de chimiothérapie mais une immunothérapie périopératoire : l’essai de phase II GERCOR NEONIPIGA vient d’être ouvert au recrutement-Reference-Cited by-同舟云学术

Patients atteints d’un cancer gastrique localisé MSI/dMMR, pas de chimiothérapie mais une immunothérapie périopératoire : l’essai de phase II GERCOR NEONIPIGA vient d’être ouvert au recrutement

Published:2020-04 Issue:4 Volume:107 Page:438-446
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:fr
Short-container-title:Bulletin du Cancer

Author:

Cohen Romain,Pudlarz Thomas,Garcia-Larnicol Marie-Line,Vernerey Dewi,Dray Xavier,Clavel Léa,Jary Marine,Piessen Guillaume,Zaanan Aziz,Aparicio Thomas,Louvet Christophe,Tournigand Christophe,Chibaudel Benoist,Tougeron David,Guimbaud Rosine,Bennouna Jaafar,Adenis Antoine,Sokol Harry,Borg Christophe,Duval Alex,Svrcek Magali,André Thierry

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference34 articles.

1. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

2. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer;Cunningham;N Engl J Med,2006

3. The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses;Kim;Int J Cancer,2015

4. Mismatch repair deficiency, microsatellite instability, and survival: an exploratory analysis of the medical research council adjuvant gastric infusional chemotherapy (MAGIC) trial;Smyth;JAMA Oncol,2017

5. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study;Choi;Ann Surg,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of a programmed cell death 1 inhibitor combined with oxaliplatin plus S-1 in patients with Borrmann large type III and IV gastric cancers;World Journal of Gastrointestinal Oncology;2024-04-15

2. Tumor recurrence after pathological complete response in locally advanced gastric cancer after neoadjuvant therapy: Two case reports;World Journal of Clinical Cases;2023-09-26

3. Traitements péri-opératoires des adénocarcinomes œsogastriques localisés;Bulletin du Cancer;2023-05

4. Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers;International Journal of Molecular Sciences;2022-08-05

5. Neoadjuvant treatment in gastric cancer;memo - Magazine of European Medical Oncology;2022-07-19